Private Wealth Partners Has Trimmed Ironwood Pharmaceuticals (IRWD) Holding; Scotia Capital Cut Dollar Gen New (DG) Stake

February 18, 2018 - By Nellie Frank

Private Wealth Partners Llc decreased Ironwood Pharmaceuticals Inc (IRWD) stake by 77.05% reported in 2017Q3 SEC filing. Private Wealth Partners Llc sold 38,200 shares as Ironwood Pharmaceuticals Inc (IRWD)’s stock rose 3.03%. The Private Wealth Partners Llc holds 11,380 shares with $179,000 value, down from 49,580 last quarter. Ironwood Pharmaceuticals Inc now has $2.30 billion valuation. The stock decreased 0.90% or $0.14 during the last trading session, reaching $15.36. About 1.44 million shares traded. Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) has risen 57.40% since February 18, 2017 and is uptrending. It has outperformed by 40.70% the S&P500.

Scotia Capital Inc decreased Dollar Gen Corp New (DG) stake by 16.96% reported in 2017Q3 SEC filing. Scotia Capital Inc sold 3,895 shares as Dollar Gen Corp New (DG)’s stock declined 7.36%. The Scotia Capital Inc holds 19,065 shares with $1.55 million value, down from 22,960 last quarter. Dollar Gen Corp New now has $26.54B valuation. The stock decreased 0.73% or $0.72 during the last trading session, reaching $97.73. About 1.79 million shares traded. Dollar General Corporation (NYSE:DG) has declined 12.26% since February 18, 2017 and is downtrending. It has underperformed by 28.96% the S&P500.

Investors sentiment decreased to 0.91 in 2017 Q3. Its down 0.07, from 0.98 in 2017Q2. It dropped, as 58 investors sold DG shares while 187 reduced holdings. 56 funds opened positions while 167 raised stakes. 237.14 million shares or 1.40% less from 240.50 million shares in 2017Q2 were reported. Creative Planning reported 6,544 shares. American National Registered Inv Advisor invested in 0.23% or 5,721 shares. Srb holds 2,338 shares or 0.02% of its portfolio. Epoch Invest Prns has 1.79 million shares. Employees Retirement Sys Of Texas has invested 0.11% of its portfolio in Dollar General Corporation (NYSE:DG). Polen Capital Management Limited Liability Corp holds 3.22% or 4.94 million shares. 34,900 were accumulated by South Dakota Invest Council. Catawba Va reported 58,805 shares. Moreover, Whittier Trust has 0% invested in Dollar General Corporation (NYSE:DG) for 905 shares. Manufacturers Life The holds 305,410 shares or 0.03% of its portfolio. Hudson Valley Invest Advisors Adv holds 0.32% or 15,233 shares in its portfolio. Meiji Yasuda Asset Mngmt Limited has invested 0.03% in Dollar General Corporation (NYSE:DG). Farmers Merchants Investments accumulated 0% or 98 shares. Moreover, Lyons Wealth Ltd Liability has 1.31% invested in Dollar General Corporation (NYSE:DG). Hellman Jordan Communications Incorporated Ma reported 1.79% in Dollar General Corporation (NYSE:DG).

Since September 12, 2017, it had 0 insider buys, and 5 selling transactions for $3.04 million activity. Ravener Robert D sold $1.06M worth of stock or 11,368 shares. Shares for $683,092 were sold by Kindy Michael J. ELLIOTT ANITA C sold $186,747 worth of stock or 2,012 shares. TAYLOR RHONDA had sold 2,711 shares worth $251,895.

Analysts await Dollar General Corporation (NYSE:DG) to report earnings on March, 15. They expect $1.45 EPS, down 2.68% or $0.04 from last year’s $1.49 per share. DG’s profit will be $393.77 million for 16.85 P/E if the $1.45 EPS becomes a reality. After $0.98 actual EPS reported by Dollar General Corporation for the previous quarter, Wall Street now forecasts 47.96% EPS growth.

Scotia Capital Inc increased Vanguard Bd Index Fd Inc (BSV) stake by 7,098 shares to 9,923 valued at $792,000 in 2017Q3. It also upped Ishares Tr (PFF) stake by 24,361 shares and now owns 48,990 shares. Comcast Corp New (NASDAQ:CMCSA) was raised too.

Among 30 analysts covering Dollar General Corp. (NYSE:DG), 17 have Buy rating, 2 Sell and 11 Hold. Therefore 57% are positive. Dollar General Corp. had 102 analyst reports since August 13, 2015 according to SRatingsIntel. The rating was maintained by Morgan Stanley on Monday, July 18 with “Overweight”. The stock of Dollar General Corporation (NYSE:DG) earned “Buy” rating by Piper Jaffray on Sunday, August 20. On Friday, November 10 the stock rating was maintained by RBC Capital Markets with “Buy”. M Partners maintained Dollar General Corporation (NYSE:DG) rating on Friday, December 4. M Partners has “Buy” rating and $82 target. The firm has “Outperform” rating given on Wednesday, December 2 by RBC Capital Markets. The company was maintained on Friday, August 25 by Bank of America. The stock of Dollar General Corporation (NYSE:DG) earned “Hold” rating by Deutsche Bank on Friday, August 26. The firm earned “Neutral” rating on Monday, August 7 by Buckingham Research. The company was downgraded on Monday, August 15 by Jefferies. RBC Capital Markets maintained Dollar General Corporation (NYSE:DG) rating on Monday, August 7. RBC Capital Markets has “Buy” rating and $8500 target.

Private Wealth Partners Llc increased Priceline Grp Inc (NASDAQ:PCLN) stake by 3,271 shares to 3,844 valued at $7.04 million in 2017Q3. It also upped Costco Whsl Corp New (NASDAQ:COST) stake by 8,424 shares and now owns 41,673 shares. Schwab Charles Corp New (NYSE:SCHW) was raised too.

Among 15 analysts covering Ironwood Pharmaceuticals (NASDAQ:IRWD), 4 have Buy rating, 2 Sell and 9 Hold. Therefore 27% are positive. Ironwood Pharmaceuticals had 37 analyst reports since August 6, 2015 according to SRatingsIntel. The stock has “Buy” rating by Cowen & Co on Friday, August 4. Barclays Capital maintained Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) rating on Friday, February 19. Barclays Capital has “Equal-Weight” rating and $11 target. The stock of Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) has “Sell” rating given on Friday, January 5 by Bank of America. As per Thursday, July 20, the company rating was maintained by Cowen & Co. The stock has “Buy” rating by Mizuho on Tuesday, June 6. The firm has “Hold” rating by J.P. Morgan given on Friday, July 21. On Monday, October 24 the stock rating was maintained by Wedbush with “Neutral”. The stock of Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) earned “Outperform” rating by Cowen & Co on Wednesday, April 6. The firm has “Buy” rating given on Friday, November 4 by Mizuho. As per Monday, October 10, the company rating was maintained by Mizuho.

Analysts await Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) to report earnings on February, 20. They expect $-0.22 earnings per share, down 83.33% or $0.10 from last year’s $-0.12 per share. After $-0.18 actual earnings per share reported by Ironwood Pharmaceuticals, Inc. for the previous quarter, Wall Street now forecasts 22.22% negative EPS growth.

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Posts

>